Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials
Authors
Keywords
-
Journal
HEADACHE
Volume 59, Issue 6, Pages 834-847
Publisher
Wiley
Online
2019-04-03
DOI
10.1111/head.13508
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- A Review of Monoclonal Antibody Therapies and Other Preventative Treatments in Migraine
- (2018) Uwe Reuter HEADACHE
- The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies
- (2018) Rebecca Burch et al. HEADACHE
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Theo Vos et al. LANCET
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Topiramate in Migraine Prevention: A 2016 Perspective
- (2016) Stephen D. Silberstein HEADACHE
- Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
- (2015) Andrew F. Russo Annual Review of Pharmacology and Toxicology
- Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain
- (2014) R.J. Benschop et al. OSTEOARTHRITIS AND CARTILAGE
- IgG Subclasses and Allotypes: From Structure to Effector Functions
- (2014) Gestur Vidarsson et al. Frontiers in Immunology
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators
- (2012) et al. CEPHALALGIA
- The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs
- (2009) Carlos M. Villalón et al. PHARMACOLOGY & THERAPEUTICS
- The Importance of Placebo in Headache Research
- (2008) H-C Diener et al. CEPHALALGIA
- Placebo response in the prophylaxis of migraine: A meta-analysis
- (2007) Ana Macedo et al. EUROPEAN JOURNAL OF PAIN
- The persistence of the placebo response in antidepressant clinical trials
- (2007) Arif Khan et al. JOURNAL OF PSYCHIATRIC RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started